We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
-0.72%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+386.48%
AUM
$16.7B
AUM Growth
-$332M
Cap. Flow
-$57.8M
Cap. Flow %
-0.35%
Top 10 Hldgs %
17.41%
Holding
2,287
New
114
Increased
795
Reduced
1,162
Closed
171
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OMF icon
1251
OneMain Financial
OMF
$7.47B
$1.38M 0.01%
24,885
+5,460
+28% +$317K
NEU icon
1252
NewMarket
NEU
$8.18B
$1.38M 0.01%
4,058
-32
-0.8% -$10.5K
ASB icon
1253
Associated Banc-Corp
ASB
$5.91B
$1.37M 0.01%
63,951
-87,714
-58% -$1.78M
ALSN icon
1254
Allison Transmission
ALSN
$9.82B
$1.37M 0.01%
38,731
+13,874
+56% +$529K
ESNT icon
1255
Essent Group
ESNT
$6.33B
$1.37M 0.01%
31,069
+3,920
+14% +$178K
RQI icon
1256
Cohen & Steers Quality Income Realty Fund
RQI
$1.69B
$1.37M 0.01%
91,703
-895
-1% -$14.3K
HTGC icon
1257
Hercules Capital
HTGC
$3.23B
$1.36M 0.01%
82,130
-70,214
-46% -$1.19M
RGA icon
1258
Reinsurance Group of America
RGA
$16.1B
$1.36M 0.01%
12,254
-9,253
-43% -$1.05M
DNA.WS
1259
DELISTED
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
$1.36M 0.01%
+401,252
New +$1.43M
GHC icon
1260
Graham Holdings Company
GHC
$5.02B
$1.36M 0.01%
2,301
-1,922
-46% -$1.2M
USNA icon
1261
Usana Health Sciences
USNA
$286M
$1.35M 0.01%
+14,695
New +$1.41M
CRNC icon
1262
Cerence
CRNC
$414M
$1.35M 0.01%
+14,070
New +$1.54M
CTR
1263
DELISTED
ClearBridge MLP and Midstream Total Return Fund Inc.
CTR
$1.35M 0.01%
56,291
+3,037
+6% +$71.5K
PTCT icon
1264
PTC Therapeutics
PTCT
$6.12B
$1.35M 0.01%
36,280
-254
-0.7% -$10.4K
AWR icon
1265
American States Water
AWR
$3.46B
$1.35M 0.01%
15,774
-1,276
-7% -$112K
ARCC icon
1266
Ares Capital
ARCC
$14.4B
$1.35M 0.01%
66,307
-55,313
-45% -$1.11M
ECF
1267
Ellsworth Growth & Income Fund
ECF
$172M
$1.35M 0.01%
100,750
-81,417
-45% -$1.18M
EGRX
1268
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$1.34M 0.01%
24,057
+7,186
+43% +$354K
CAI
1269
DELISTED
CAI International, Inc.
CAI
$1.34M 0.01%
+23,986
New +$1.34M
CLB icon
1270
Core Laboratories
CLB
$521M
$1.34M 0.01%
48,204
+18,984
+65% +$578K
LXP icon
1271
LXP Industrial Trust
LXP
$3.57B
$1.33M 0.01%
20,912
-8,102
-28% -$531K
UBS icon
1272
UBS Group
UBS
$176B
$1.32M 0.01%
83,156
+2,154
+3% +$34.9K
VOD icon
1273
Vodafone
VOD
$37.4B
$1.32M 0.01%
85,703
-18,085
-17% -$299K
EGP icon
1274
EastGroup Properties
EGP
$10.9B
$1.32M 0.01%
7,923
-4,248
-35% -$738K
CNR
1275
Core Natural Resources Inc
CNR
$4.45B
$1.31M 0.01%
50,489
-88,525
-64% -$1.95M

Similar funds

Guggenheim Capital's Q3 2021 Portfolio in Review

As of Q3 2021, Guggenheim Capital held 2,287 positions worth $16.7B, down 2% from $17B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Guggenheim Capital's Q3 2021 filing shows 114 new, 795 increased, 1,162 reduced and 171 closed positions. Its largest new stake was Logistics Innovation Technologies Corp. Class A Common Stock: 4,000,000 shares worth $38.6M. The largest sale was Alexion Pharmaceuticals, an estimated $41.8M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • Guggenheim Capital's largest Q3 2021 buy was Logistics Innovation Technologies Corp. Class A Common Stock: 4,000,000 shares worth $38.6M.
  • Guggenheim Capital added most to iShares Core US Aggregate Bond ETF in Q3 2021, an estimated $50M increase.
  • Guggenheim Capital's biggest Q3 2021 reduction was Matterport, Inc. Class A Common Stock, cutting an estimated $32.4M.
  • Guggenheim Capital fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $41.8M.
  • Guggenheim Capital's ten largest holdings make up 17% of its $16.7B portfolio in Q3 2021.
  • Guggenheim Capital opened 114 new positions and closed 171 in Q3 2021.
  • Guggenheim Capital's portfolio value fell 2% quarter-over-quarter to $16.7B.

Based on Guggenheim Capital's 13F filing for Q3 2021, filed 15 Nov 2021.